Former vice president Joe Biden and his wife Jill stepped down from the board of the Biden Cancer Initiative in April to focus on the 2020 presidential campaign.

Three months later, both Biden’s campaign and his namesake nonprofit are sputtering to a stall, with the latter suspending operations indefinitely.

The Biden Cancer Initiative, started just two years ago, promised $400 million to boost cancer treatment, but after Biden and his wife left in April, “the nonprofit had trouble maintaining momentum without their involvement,” KYW-TV reports.

The Biden campaign for president, meanwhile, is having trouble maintaining momentum with their involvement.

The latest poll from New Hampshire, the first primary state, shows Biden’s support has slipped from 22.9 percent in early April to 20.8 percent in July, while support for Sen. Kamala Harris went from 7 percent in April to 18 percent in July, according to Real Clear Politics.

The swift shift followed Biden’s bungled performance in the Democratic primary debate in June, when Harris attacked the 76-year-old on his proud cooperation with segregationists and opposition to segregated busing earlier in his long career in politics.

That snafu came after several other embarrassing stumbles, including revelations the Biden campaign plagiarized policy proposals – an issue that tanked his first run for president, a flip-flop-flip on his decades of support for the Hyde Amendment prohibiting taxpayer-funded abortions, and the looming non-endorsement from his former boss, Barack Obama, among others.

National polling data show Biden launched his campaign with as much as 46 percent support from Democrat voters – a 32 percentage point lead over the next closest candidate, Bernie Sanders. Since that early May poll from The Hill/HarrisX, Biden’s support has slid to a low of 22 percent in an Economist/YouGov poll last week. That poll put Sen. Elizabeth Warren just four percentage points behind at 18 percent, with Harris in third with 15 percent.

The RCP average for all polls since July 6 puts Biden at 27.8 percent support from Democrat voters, followed by Sanders and Warren tied with 15 percent and Harris at 13 percent.

The indefinite end to the Biden Cancer Initiative may be a preemptive effort to minimize future problems looming on the horizon for the Biden campaign. The Associated Press noted the nonprofit worked closely to build partnerships between drug companies, health care firms, charities and other organizations.

The Biden Cancer initiative took in millions in direct funding, but many of the nonprofit’s partnerships touted by the former vice president already existed as part of a Cancer Moonshot program he launched while in office and carried over to the foundation. Many of the drug and health care companies that participated are also deeply involved in lobbying politicians in Washington, D.C.

The AP reports:

An Associated Press examination of the nonprofit’s partnership program and Biden’s speeches on behalf its activities found last month that in some cases health care world entities and allies touted by the former vice president were already lobbying for interests before the federal government.

In January 2018, Biden spoke at a San Francisco conference sponsored by a health tech firm whose chief medical officer is Biden’s son-in-law, who was also on the Biden cancer nonprofit’s board. During that speech, Biden also hailed a medical device entrepreneur who has helped raise funds for Biden’s campaign. Both firms lobby with the federal government.

Similarly, the Biden nonprofit promotes commitments from at least a dozen major drug firms that lobby with the government.

The nonprofit’s collaborations with pharmaceutical firms could also have complicated Biden’s new health-care policy outlined today. Biden promised to “stand up to the abuse of power by prescription drug corporations if elected.”

Many of the partnerships touted by Biden have turned out to be “not successful,” the nonprofit’s executive director Greg Simon said.

Without Biden’s “convening power and ability to get issues to the top of the list” the Cancer Initiative named after him essentially shriveled, he told the AP.

“We tried to power through but it became increasingly difficult to get the traction we needed to complete our mission,” Simon said.